Stagliano Nancy
Insider CIK 1817449 · PAND Director · ETRA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-21 | 255,635 | — | $0 | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-21 | 255,635 | — | $0 | 255,635 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion deriv | 2026-09-21 | 2026-09-21 | 255,635 | — | — | 0 | SEC↗ |
| ETRA Electra Therapeutics, Inc. | C Conversion | 2026-09-21 | 2026-09-21 | 255,635 | — | — | 255,635 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | D To issuer deriv | 2021-04-01 | 2021-04-01 | 17,671 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | U Tender | 2021-04-01 | 2021-04-01 | 73,067 | $60.00 | $4.38M | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | U Tender | 2021-04-01 | 2021-04-01 | 1,000 | $60.00 | $60.0K | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion deriv | 2020-07-21 | 2020-07-21 | 47,898 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion deriv | 2020-07-21 | 2020-07-21 | 28,620 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | P Buy | 2020-07-21 | 2020-07-21 | 1,000 | $18.00 | $18.0K | 1,000 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion | 2020-07-21 | 2020-07-21 | 15,004 | — | $0 | 73,067 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | A Award deriv | 2020-07-17 | 2020-07-21 | 3,674 | — | $0 | 3,674 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | A Award deriv | 2020-07-17 | 2020-07-21 | 13,997 | — | $0 | 13,997 | SEC↗ |